THE ROLE OF ISA DETERMINATION BY ELISA IN THE EARLY SERODIAGNOSIS OF MYCOPLASMA-PNEUMONIAE INFECTION, IN RELATION TO IGG AND MU-CAPTURE IGM METHODS

被引:20
作者
GRANSTROM, M
HOLME, T
SJOGREN, AM
ORTQVIST, A
KALIN, M
机构
[1] KAROLINSKA INST,DEPT BACTERIOL,S-10401 STOCKHOLM,SWEDEN
[2] DANDERYD HOSP,DEPT INFECT DIS,S-18288 DANDERYD,SWEDEN
关键词
D O I
10.1099/00222615-40-4-288
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Enzyme-linked immunosorbent assay (ELISA) for IgA, IgG and IgM was evaluated with sera from 50 adult patients with pneumonia, selected on the basis of a positive complement fixation (CF) test for diagnosis of Mycoplasma pneumoniae infection and with sera from 105 healthy blood donors. The ELISA antigen for Ige and IgA was a sonicated suspension of M. pneumoniae solubilised by deoxycholate. For the IgM assay, the same antigen was directly conjugated to alkaline phosphatase and used in a mu-capture format. ELISA gave positive results with high or rising titres for one or several antibody classes in 47 (94 %) patients. In two of the three ELISA-negative cases, the diagnosis of M. pneumoniae infection indicated by the CF test seemed unlikely on clinical grounds. Specific IgA antibodies was developed more regularly and more rapidly than IgM. IgA titres also started to decrease earlier than IgM or the late-peaking Ige response. Thus, the determination of IgA antibodies was found to be valuable for the early diagnosis of M. pneumoniae infection. The study also demonstrated that the determination of all three antibody classes is necessary to obtain an optimal level of serodiagnosis.
引用
收藏
页码:288 / 292
页数:5
相关论文
共 26 条
[1]  
CLYDE WA, 1984, CUMITECH, V19, P5
[3]   COMPARISON OF ENZYME-LINKED IMMUNOSORBENT-ASSAY (ELISA) AND COMPLEMENT-FIXATION TEST FOR DETECTION OF MYCOPLASMA-PNEUMONIAE ANTIBODIES [J].
DUSSAIX, E ;
SLIM, A ;
TOURNIER, P .
JOURNAL OF CLINICAL PATHOLOGY, 1983, 36 (02) :228-232
[4]   DIAGNOSIS OF MYCOPLASMA-PNEUMONIAE INFECTION BY MICROPARTICLE AGGLUTINATION AND ANTIBODY-CAPTURE ENZYME-IMMUNOASSAY [J].
ECHEVARRIA, JM ;
LEON, P ;
BALFAGON, P ;
LOPEZ, JA ;
FERNANDEZ, MV .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1990, 9 (03) :217-220
[5]  
ENGVALL E, 1972, J IMMUNOL, V109, P129
[6]   PREDICTION OF MICROBIAL ETIOLOGY AT ADMISSION TO HOSPITAL FOR PNEUMONIA FROM THE PRESENTING CLINICAL-FEATURES [J].
FARR, BM ;
KAISER, DL ;
HARRISON, BDW ;
CONNOLLY, CK .
THORAX, 1989, 44 (12) :1031-1035
[7]  
HIRSCHBERG L, 1990, ZBL BAKT S, V20, P771
[8]   ENZYME-LINKED IMMUNOSORBENT-ASSAY FOR DETECTION OF MYCOPLASMA-PNEUMONIAE SPECIFIC IMMUNOGLOBULIN-M [J].
HIRSCHBERG, L ;
KROOK, A ;
PETTERSSON, CA ;
VIKERFORS, T .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1988, 7 (03) :420-423
[9]   IGG RESPONSE TO MYCOPLASMA-PNEUMONIAE IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA DETERMINED BY ELISA [J].
HIRSCHBERG, L ;
HOLME, T ;
KROOK, A ;
VIKERFORS, T .
APMIS, 1988, 96 (07) :605-610
[10]   REACTION PATTERN OF HUMAN ANTI-MYCOPLASMA-PNEUMONIAE ANTIBODIES IN ENZYME-LINKED IMMUNOSORBENT ASSAYS AND IMMUNOBLOTTING [J].
JACOBS, E ;
BENNEWITZ, A ;
BREDT, W .
JOURNAL OF CLINICAL MICROBIOLOGY, 1986, 23 (03) :517-522